Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ABC transporters 💬 3 genes, 10 drugs (DrugBank) and 8 diseases |
ABCC8 [1] ABCC8 💬ABC transporters
|
Diazoxide Diazoxide 💬ABC transporters
| Diazoxide | 013 [2] 13, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | Acute myeloid leukemia 💬 17 genes, 30 drugs (DrugBank) and 62 diseases |
MTOR [1] MTOR 💬Acute myeloid leukemia
|
Sirolimus Sirolimus 💬Acute myeloid leukemia
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬2. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Adipocytokine signaling pathway 💬 16 genes, 31 drugs (DrugBank) and 95 diseases |
MTOR [1] MTOR 💬Adipocytokine signaling pathway
|
Sirolimus Sirolimus 💬Adipocytokine signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬3. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Adrenergic signaling in cardiomyocytes 💬 27 genes, 80 drugs (DrugBank) and 71 diseases |
ADRB1 [1] ADRB1 💬Adrenergic signaling in cardiomyocytes
|
Metoprolol Metoprolol 💬Adrenergic signaling in cardiomyocytes
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Adrenergic signaling in cardiomyocytes 💬 27 genes, 80 drugs (DrugBank) and 71 diseases |
CACNA1C [5] CACNA1C, CACNA1D, CACNA1F, CACNA1S, SCN5A 💬Adrenergic signaling in cardiomyocytes |
Topiramate Topiramate 💬Adrenergic signaling in cardiomyocytes
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Aldosterone synthesis and secretion 💬 20 genes, 38 drugs (DrugBank) and 62 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Aldosterone synthesis and secretion
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Alzheimer disease 💬 55 genes, 116 drugs (DrugBank) and 122 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Alzheimer disease
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Alzheimer disease 💬 55 genes, 116 drugs (DrugBank) and 122 diseases |
MTOR [1] MTOR 💬Alzheimer disease
|
Sirolimus Sirolimus 💬Alzheimer disease
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬8. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Amphetamine addiction 💬 25 genes, 51 drugs (DrugBank) and 91 diseases |
CACNA1C [6] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4 💬Amphetamine addiction
|
Topiramate Topiramate 💬Amphetamine addiction
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | AMPK signaling pathway 💬 16 genes, 49 drugs (DrugBank) and 93 diseases |
MTOR [1] MTOR 💬AMPK signaling pathway
|
Sirolimus Sirolimus 💬AMPK signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬10. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | Amyotrophic lateral sclerosis 💬 35 genes, 48 drugs (DrugBank) and 108 diseases |
GRIA1 [2] GRIA1, GRIA2 💬
|
Topiramate Topiramate 💬Amyotrophic lateral sclerosis
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | Amyotrophic lateral sclerosis 💬 35 genes, 48 drugs (DrugBank) and 108 diseases |
MTOR [1] MTOR 💬Amyotrophic lateral sclerosis
|
Sirolimus Sirolimus 💬Amyotrophic lateral sclerosis
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬12. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Apelin signaling pathway 💬 12 genes, 30 drugs (DrugBank) and 72 diseases |
MTOR [1] MTOR 💬Apelin signaling pathway
|
Sirolimus Sirolimus 💬Apelin signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬13. Apelin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | Arrhythmogenic right ventricular cardiomyopathy 💬 11 genes, 24 drugs (DrugBank) and 28 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Arrhythmogenic right ventricular cardiomyopathy
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | Autophagy - animal 💬 13 genes, 18 drugs (DrugBank) and 62 diseases |
MTOR [1] MTOR 💬Autophagy - animal
|
Sirolimus Sirolimus 💬Autophagy - animal
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬15. Autophagy - animal
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | Autophagy - other 💬 1 gene, 3 drugs (DrugBank) and 41 diseases |
MTOR [1] MTOR 💬Autophagy - other
|
Sirolimus Sirolimus 💬Autophagy - other
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬16. Autophagy - other
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | Bile secretion 💬 11 genes, 29 drugs (DrugBank) and 60 diseases |
CA2 [1] CA2 💬Bile secretion
|
Topiramate Topiramate 💬Bile secretion
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | Breast cancer 💬 21 genes, 60 drugs (DrugBank) and 74 diseases |
MTOR [1] MTOR 💬Breast cancer
|
Sirolimus Sirolimus 💬Breast cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬18. Breast cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
ADRB1 [1] ADRB1 💬Calcium signaling pathway
|
Metoprolol Metoprolol 💬Calcium signaling pathway
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Calcium signaling pathway
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
OXTR [1] OXTR 💬Calcium signaling pathway
|
Oxytocin Oxytocin 💬Calcium signaling pathway
| Oxytocin | 006 [7] 6 , 72, 127, 168, 193, 206, 226 💬21. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 | cAMP signaling pathway 💬 67 genes, 171 drugs (DrugBank) and 114 diseases |
ADRB1 [1] ADRB1 💬cAMP signaling pathway
|
Metoprolol Metoprolol 💬cAMP signaling pathway
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 | cAMP signaling pathway 💬 67 genes, 171 drugs (DrugBank) and 114 diseases |
CACNA1C [8] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GRIA1, GRIA2, GRIA3, GRIA4 💬cAMP signaling pathway
|
Topiramate Topiramate 💬cAMP signaling pathway
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 | cAMP signaling pathway 💬 67 genes, 171 drugs (DrugBank) and 114 diseases |
GLP1R [1] GLP1R 💬cAMP signaling pathway
|
Exenatide Exenatide 💬cAMP signaling pathway
| Exenatide | 006 [6] 6 , 17, 72, 78, 193, 233 💬24. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 | cAMP signaling pathway 💬 67 genes, 171 drugs (DrugBank) and 114 diseases |
GLP1R [1] GLP1R 💬cAMP signaling pathway
|
Liraglutide Liraglutide 💬cAMP signaling pathway
| Liraglutide | 006 [3] 6 , 75, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 | cAMP signaling pathway 💬 67 genes, 171 drugs (DrugBank) and 114 diseases |
OXTR [1] OXTR 💬cAMP signaling pathway
|
Oxytocin Oxytocin 💬cAMP signaling pathway
| Oxytocin | 006 [7] 6 , 72, 127, 168, 193, 206, 226 💬26. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 | cAMP signaling pathway 💬 67 genes, 171 drugs (DrugBank) and 114 diseases |
SSTR2 [1] SSTR2 💬cAMP signaling pathway
|
Octreotide Octreotide 💬cAMP signaling pathway
| Octreotide | 067 [7] 67, 75, 84, 85, 89, 193, 227 💬27. cAMP signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
28 | Carbohydrate digestion and absorption 💬 14 genes, 19 drugs (DrugBank) and 30 diseases |
CACNA1D [1] CACNA1D 💬Carbohydrate digestion and absorption
|
Topiramate Topiramate 💬Carbohydrate digestion and absorption
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
29 | Cardiac muscle contraction 💬 13 genes, 17 drugs (DrugBank) and 26 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Cardiac muscle contraction
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
30 | Cellular senescence 💬 26 genes, 40 drugs (DrugBank) and 92 diseases |
CACNA1D [1] CACNA1D 💬Cellular senescence
|
Topiramate Topiramate 💬Cellular senescence
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31 | Cellular senescence 💬 26 genes, 40 drugs (DrugBank) and 92 diseases |
MTOR [1] MTOR 💬Cellular senescence
|
Sirolimus Sirolimus 💬Cellular senescence
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬31. Cellular senescence
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
32 | Central carbon metabolism in cancer 💬 18 genes, 29 drugs (DrugBank) and 56 diseases |
MTOR [1] MTOR 💬Central carbon metabolism in cancer
|
Sirolimus Sirolimus 💬Central carbon metabolism in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬32. Central carbon metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | cGMP-PKG signaling pathway 💬 46 genes, 119 drugs (DrugBank) and 118 diseases |
ADRA2A [1] ADRA2A 💬cGMP-PKG signaling pathway
|
Guanfacine Guanfacine 💬cGMP-PKG signaling pathway
| Guanfacine | 193 [1] 193 💬33. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
34 | cGMP-PKG signaling pathway 💬 46 genes, 119 drugs (DrugBank) and 118 diseases |
ADRB1 [1] ADRB1 💬cGMP-PKG signaling pathway
|
Metoprolol Metoprolol 💬cGMP-PKG signaling pathway
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
35 | cGMP-PKG signaling pathway 💬 46 genes, 119 drugs (DrugBank) and 118 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬cGMP-PKG signaling pathway
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases |
ADRB1 [1] ADRB1 💬Chemical carcinogenesis - receptor activation
|
Metoprolol Metoprolol 💬Chemical carcinogenesis - receptor activation
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Chemical carcinogenesis - receptor activation
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases |
MTOR [1] MTOR 💬Chemical carcinogenesis - receptor activation
|
Sirolimus Sirolimus 💬Chemical carcinogenesis - receptor activation
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬38. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
39 | Choline metabolism in cancer 💬 11 genes, 25 drugs (DrugBank) and 53 diseases |
MTOR [1] MTOR 💬Choline metabolism in cancer
|
Sirolimus Sirolimus 💬Choline metabolism in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬39. Choline metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40 | Cholinergic synapse 💬 32 genes, 48 drugs (DrugBank) and 59 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Cholinergic synapse
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41 | Circadian entrainment 💬 22 genes, 32 drugs (DrugBank) and 55 diseases |
CACNA1C [6] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4 💬Circadian entrainment
|
Topiramate Topiramate 💬Circadian entrainment
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42 | Cocaine addiction 💬 15 genes, 63 drugs (DrugBank) and 52 diseases |
GRIA2 [1] GRIA2 💬Cocaine addiction
|
Topiramate Topiramate 💬Cocaine addiction
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43 | Collecting duct acid secretion 💬 3 genes, 11 drugs (DrugBank) and 35 diseases |
CA2 [1] CA2 💬Collecting duct acid secretion
|
Topiramate Topiramate 💬Collecting duct acid secretion
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44 | Colorectal cancer 💬 14 genes, 23 drugs (DrugBank) and 49 diseases |
MTOR [1] MTOR 💬Colorectal cancer
|
Sirolimus Sirolimus 💬Colorectal cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬44. Colorectal cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45 | Cortisol synthesis and secretion 💬 15 genes, 33 drugs (DrugBank) and 61 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Cortisol synthesis and secretion
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
46 | Cushing syndrome 💬 24 genes, 50 drugs (DrugBank) and 66 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Cushing syndrome
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
47 | Diabetic cardiomyopathy 💬 26 genes, 42 drugs (DrugBank) and 73 diseases |
MTOR [1] MTOR 💬Diabetic cardiomyopathy
|
Sirolimus Sirolimus 💬Diabetic cardiomyopathy
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬47. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
48 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases |
ADRB1 [1] ADRB1 💬Dilated cardiomyopathy
|
Metoprolol Metoprolol 💬Dilated cardiomyopathy
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
49 | Dilated cardiomyopathy 💬 17 genes, 55 drugs (DrugBank) and 83 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Dilated cardiomyopathy
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
50 | Dopaminergic synapse 💬 31 genes, 99 drugs (DrugBank) and 101 diseases |
CACNA1C [7] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4, SCN1A 💬Dopaminergic synapse
|
Topiramate Topiramate 💬Dopaminergic synapse
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
51 | EGFR tyrosine kinase inhibitor resistance 💬 26 genes, 56 drugs (DrugBank) and 83 diseases |
MTOR [1] MTOR 💬EGFR tyrosine kinase inhibitor resistance
|
Sirolimus Sirolimus 💬EGFR tyrosine kinase inhibitor resistance
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬51. EGFR tyrosine kinase inhibitor resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
52 | Endocrine resistance 💬 20 genes, 43 drugs (DrugBank) and 62 diseases |
MTOR [1] MTOR 💬Endocrine resistance
|
Sirolimus Sirolimus 💬Endocrine resistance
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬52. Endocrine resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
53 | ErbB signaling pathway 💬 14 genes, 26 drugs (DrugBank) and 53 diseases |
MTOR [1] MTOR 💬ErbB signaling pathway
|
Sirolimus Sirolimus 💬ErbB signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬53. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
54 | GABAergic synapse 💬 29 genes, 38 drugs (DrugBank) and 55 diseases |
CACNA1C [20] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬GABAergic synapse
|
Topiramate Topiramate 💬GABAergic synapse
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
55 | Gap junction 💬 26 genes, 87 drugs (DrugBank) and 77 diseases |
ADRB1 [1] ADRB1 💬Gap junction
|
Metoprolol Metoprolol 💬Gap junction
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
56 | Gastric acid secretion 💬 14 genes, 43 drugs (DrugBank) and 52 diseases |
CA2 [1] CA2 💬Gastric acid secretion
|
Topiramate Topiramate 💬Gastric acid secretion
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
57 | Gastric acid secretion 💬 14 genes, 43 drugs (DrugBank) and 52 diseases |
SSTR2 [1] SSTR2 💬Gastric acid secretion
|
Octreotide Octreotide 💬Gastric acid secretion
| Octreotide | 067 [7] 67, 75, 84, 85, 89, 193, 227 💬57. Gastric acid secretion |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
58 | Gastric cancer 💬 21 genes, 34 drugs (DrugBank) and 57 diseases |
MTOR [1] MTOR 💬Gastric cancer
|
Sirolimus Sirolimus 💬Gastric cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬58. Gastric cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
59 | Glioma 💬 15 genes, 30 drugs (DrugBank) and 57 diseases |
MTOR [1] MTOR 💬Glioma
|
Sirolimus Sirolimus 💬Glioma
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬59. Glioma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
60 | Glutamatergic synapse 💬 23 genes, 27 drugs (DrugBank) and 83 diseases |
CACNA1C [11] CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 💬Glutamatergic synapse
|
Topiramate Topiramate 💬Glutamatergic synapse
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
61 | GnRH secretion 💬 20 genes, 42 drugs (DrugBank) and 54 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬GnRH secretion
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
62 | GnRH secretion 💬 20 genes, 42 drugs (DrugBank) and 54 diseases |
KCNJ11 [1] KCNJ11 💬GnRH secretion
|
Diazoxide Diazoxide 💬GnRH secretion
| Diazoxide | 013 [2] 13, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
63 | GnRH signaling pathway 💬 16 genes, 36 drugs (DrugBank) and 37 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬GnRH signaling pathway
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
64 | Growth hormone synthesis, secretion and action 💬 24 genes, 41 drugs (DrugBank) and 76 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Growth hormone synthesis, secretion and action
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
65 | Growth hormone synthesis, secretion and action 💬 24 genes, 41 drugs (DrugBank) and 76 diseases |
MTOR [1] MTOR 💬Growth hormone synthesis, secretion and action
|
Sirolimus Sirolimus 💬Growth hormone synthesis, secretion and action
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬65. Growth hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
66 | Growth hormone synthesis, secretion and action 💬 24 genes, 41 drugs (DrugBank) and 76 diseases |
SSTR2 [1] SSTR2 💬Growth hormone synthesis, secretion and action
|
Octreotide Octreotide 💬Growth hormone synthesis, secretion and action
| Octreotide | 067 [7] 67, 75, 84, 85, 89, 193, 227 💬66. Growth hormone synthesis, secretion and action |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
67 | Hepatocellular carcinoma 💬 21 genes, 31 drugs (DrugBank) and 57 diseases |
MTOR [1] MTOR 💬Hepatocellular carcinoma
|
Sirolimus Sirolimus 💬Hepatocellular carcinoma
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬67. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
68 | Herpes simplex virus 1 infection 💬 43 genes, 65 drugs (DrugBank) and 94 diseases |
MTOR [1] MTOR 💬Herpes simplex virus 1 infection
|
Sirolimus Sirolimus 💬Herpes simplex virus 1 infection
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬68. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
69 | HIF-1 signaling pathway 💬 23 genes, 48 drugs (DrugBank) and 76 diseases |
MTOR [1] MTOR 💬HIF-1 signaling pathway
|
Sirolimus Sirolimus 💬HIF-1 signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬69. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
70 | Human cytomegalovirus infection 💬 56 genes, 104 drugs (DrugBank) and 120 diseases |
MTOR [1] MTOR 💬Human cytomegalovirus infection
|
Sirolimus Sirolimus 💬Human cytomegalovirus infection
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬70. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
71 | Human immunodeficiency virus 1 infection 💬 41 genes, 43 drugs (DrugBank) and 89 diseases |
MTOR [1] MTOR 💬Human immunodeficiency virus 1 infection
|
Sirolimus Sirolimus 💬Human immunodeficiency virus 1 infection
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬71. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
72 | Human papillomavirus infection 💬 40 genes, 91 drugs (DrugBank) and 105 diseases |
MTOR [1] MTOR 💬Human papillomavirus infection
|
Sirolimus Sirolimus 💬Human papillomavirus infection
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬72. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
73 | Huntington disease 💬 24 genes, 33 drugs (DrugBank) and 82 diseases |
GRIA1 [4] GRIA1, GRIA2, GRIA3, GRIA4 💬
|
Topiramate Topiramate 💬Huntington disease
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
74 | Huntington disease 💬 24 genes, 33 drugs (DrugBank) and 82 diseases |
MTOR [1] MTOR 💬Huntington disease
|
Sirolimus Sirolimus 💬Huntington disease
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬74. Huntington disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
75 | Hypertrophic cardiomyopathy 💬 20 genes, 51 drugs (DrugBank) and 87 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Hypertrophic cardiomyopathy
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
76 | Insulin resistance 💬 18 genes, 33 drugs (DrugBank) and 95 diseases |
MTOR [1] MTOR 💬Insulin resistance
|
Sirolimus Sirolimus 💬Insulin resistance
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬76. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
77 | Insulin secretion 💬 14 genes, 39 drugs (DrugBank) and 44 diseases |
ABCC8 [2] ABCC8, KCNJ11 💬
|
Diazoxide Diazoxide 💬Insulin secretion
| Diazoxide | 013 [2] 13, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
78 | Insulin secretion 💬 14 genes, 39 drugs (DrugBank) and 44 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Insulin secretion
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
79 | Insulin secretion 💬 14 genes, 39 drugs (DrugBank) and 44 diseases |
GLP1R [1] GLP1R 💬Insulin secretion
|
Exenatide Exenatide 💬Insulin secretion
| Exenatide | 006 [6] 6 , 17, 72, 78, 193, 233 💬79. Insulin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
80 | Insulin secretion 💬 14 genes, 39 drugs (DrugBank) and 44 diseases |
GLP1R [1] GLP1R 💬Insulin secretion
|
Liraglutide Liraglutide 💬Insulin secretion
| Liraglutide | 006 [3] 6 , 75, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
81 | Insulin signaling pathway 💬 12 genes, 26 drugs (DrugBank) and 66 diseases |
MTOR [1] MTOR 💬Insulin signaling pathway
|
Sirolimus Sirolimus 💬Insulin signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬81. Insulin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
82 | JAK-STAT signaling pathway 💬 58 genes, 91 drugs (DrugBank) and 96 diseases |
MTOR [1] MTOR 💬JAK-STAT signaling pathway
|
Sirolimus Sirolimus 💬JAK-STAT signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬82. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
83 | Kaposi sarcoma-associated herpesvirus infection 💬 50 genes, 84 drugs (DrugBank) and 108 diseases |
MTOR [1] MTOR 💬Kaposi sarcoma-associated herpesvirus infection
|
Sirolimus Sirolimus 💬Kaposi sarcoma-associated herpesvirus infection
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬83. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
84 | Long-term depression 💬 13 genes, 19 drugs (DrugBank) and 32 diseases |
GRIA1 [3] GRIA1, GRIA2, GRIA3 💬
|
Topiramate Topiramate 💬Long-term depression
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
85 | Long-term potentiation 💬 18 genes, 33 drugs (DrugBank) and 86 diseases |
CACNA1C [3] CACNA1C, GRIA1, GRIA2 💬
|
Topiramate Topiramate 💬Long-term potentiation
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
86 | Longevity regulating pathway 💬 11 genes, 20 drugs (DrugBank) and 68 diseases |
MTOR [1] MTOR 💬Longevity regulating pathway
|
Sirolimus Sirolimus 💬Longevity regulating pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬86. Longevity regulating pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
87 | Longevity regulating pathway - multiple species 💬 11 genes, 15 drugs (DrugBank) and 62 diseases |
MTOR [1] MTOR 💬Longevity regulating pathway - multiple species
|
Sirolimus Sirolimus 💬Longevity regulating pathway - multiple species
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬87. Longevity regulating pathway - multiple species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
88 | MAPK signaling pathway 💬 61 genes, 85 drugs (DrugBank) and 110 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬MAPK signaling pathway
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
89 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases |
CA2 [2] CA2, CA4 💬
|
Topiramate Topiramate 💬Metabolic pathways
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
90 | Metabolic pathways 💬 111 genes, 155 drugs (DrugBank) and 137 diseases |
CYP19A1 [1] CYP19A1 💬Metabolic pathways
|
Anastrozole Anastrozole 💬Metabolic pathways
| Anastrozole | 078 [3] 78, 86, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
91 | MicroRNAs in cancer 💬 31 genes, 65 drugs (DrugBank) and 85 diseases |
MTOR [1] MTOR 💬MicroRNAs in cancer
|
Sirolimus Sirolimus 💬MicroRNAs in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬91. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
92 | Morphine addiction 💬 41 genes, 65 drugs (DrugBank) and 73 diseases |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬Morphine addiction
|
Topiramate Topiramate 💬Morphine addiction
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
93 | mTOR signaling pathway 💬 14 genes, 32 drugs (DrugBank) and 91 diseases |
MTOR [1] MTOR 💬mTOR signaling pathway
|
Sirolimus Sirolimus 💬mTOR signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬93. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
94 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
ADRA2A [1] ADRA2A 💬Neuroactive ligand-receptor interaction
|
Guanfacine Guanfacine 💬Neuroactive ligand-receptor interaction
| Guanfacine | 193 [1] 193 💬94. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
95 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
ADRB1 [1] ADRB1 💬Neuroactive ligand-receptor interaction
|
Metoprolol Metoprolol 💬Neuroactive ligand-receptor interaction
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
96 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
CNR1 [1] CNR1 💬Neuroactive ligand-receptor interaction
|
Rimonabant Rimonabant 💬Neuroactive ligand-receptor interaction
| Rimonabant | 193 [1] 193 💬96. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
97 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
CNR1 [2] CNR1, CNR2 💬
|
Cannabidiol Cannabidiol 💬Neuroactive ligand-receptor interaction
| Cannabidiol | 002 [20] 2 , 6 , 8 , 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬97. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
98 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
GABRA1 [25] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 💬Neuroactive ligand-receptor interaction
|
Topiramate Topiramate 💬Neuroactive ligand-receptor interaction
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
99 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
GLP1R [1] GLP1R 💬Neuroactive ligand-receptor interaction
|
Exenatide Exenatide 💬Neuroactive ligand-receptor interaction
| Exenatide | 006 [6] 6 , 17, 72, 78, 193, 233 💬99. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
100 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
GLP1R [1] GLP1R 💬Neuroactive ligand-receptor interaction
|
Liraglutide Liraglutide 💬Neuroactive ligand-receptor interaction
| Liraglutide | 006 [3] 6 , 75, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
101 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
HRH3 [1] HRH3 💬Neuroactive ligand-receptor interaction
|
Pitolisant Pitolisant 💬Neuroactive ligand-receptor interaction
| Pitolisant | 006 [3] 6 , 113, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
102 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
OXTR [1] OXTR 💬Neuroactive ligand-receptor interaction
|
Oxytocin Oxytocin 💬Neuroactive ligand-receptor interaction
| Oxytocin | 006 [7] 6 , 72, 127, 168, 193, 206, 226 💬102. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
103 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
SSTR2 [1] SSTR2 💬Neuroactive ligand-receptor interaction
|
Octreotide Octreotide 💬Neuroactive ligand-receptor interaction
| Octreotide | 067 [7] 67, 75, 84, 85, 89, 193, 227 💬103. Neuroactive ligand-receptor interaction |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
104 | Neutrophil extracellular trap formation 💬 35 genes, 36 drugs (DrugBank) and 61 diseases |
MTOR [1] MTOR 💬Neutrophil extracellular trap formation
|
Sirolimus Sirolimus 💬Neutrophil extracellular trap formation
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬104. Neutrophil extracellular trap formation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
105 | Nicotine addiction 💬 30 genes, 30 drugs (DrugBank) and 44 diseases |
GABRA1 [20] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4 💬Nicotine addiction
|
Topiramate Topiramate 💬Nicotine addiction
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
106 | Nitrogen metabolism 💬 14 genes, 5 drugs (DrugBank) and 18 diseases |
CA2 [2] CA2, CA4 💬
|
Topiramate Topiramate 💬Nitrogen metabolism
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
107 | Ovarian steroidogenesis 💬 7 genes, 36 drugs (DrugBank) and 52 diseases |
CYP19A1 [1] CYP19A1 💬Ovarian steroidogenesis
|
Anastrozole Anastrozole 💬Ovarian steroidogenesis
| Anastrozole | 078 [3] 78, 86, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
108 | Oxytocin signaling pathway 💬 34 genes, 73 drugs (DrugBank) and 108 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Oxytocin signaling pathway
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
109 | Oxytocin signaling pathway 💬 34 genes, 73 drugs (DrugBank) and 108 diseases |
OXTR [1] OXTR 💬Oxytocin signaling pathway
|
Oxytocin Oxytocin 💬Oxytocin signaling pathway
| Oxytocin | 006 [7] 6 , 72, 127, 168, 193, 206, 226 💬109. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
110 | Pancreatic cancer 💬 19 genes, 36 drugs (DrugBank) and 67 diseases |
MTOR [1] MTOR 💬Pancreatic cancer
|
Sirolimus Sirolimus 💬Pancreatic cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬110. Pancreatic cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
111 | Pancreatic secretion 💬 13 genes, 35 drugs (DrugBank) and 36 diseases |
CA2 [1] CA2 💬Pancreatic secretion
|
Topiramate Topiramate 💬Pancreatic secretion
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
112 | Pathways in cancer 💬 104 genes, 194 drugs (DrugBank) and 133 diseases |
MTOR [1] MTOR 💬Pathways in cancer
|
Sirolimus Sirolimus 💬Pathways in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬112. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
113 | Pathways of neurodegeneration - multiple diseases 💬 59 genes, 120 drugs (DrugBank) and 125 diseases |
CACNA1C [8] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GRIA1, GRIA2, GRIA3, GRIA4 💬Pathways of neurodegeneration - multiple diseases
|
Topiramate Topiramate 💬Pathways of neurodegeneration - multiple diseases
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
114 | Pathways of neurodegeneration - multiple diseases 💬 59 genes, 120 drugs (DrugBank) and 125 diseases |
MTOR [1] MTOR 💬Pathways of neurodegeneration - multiple diseases
|
Sirolimus Sirolimus 💬Pathways of neurodegeneration - multiple diseases
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬114. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
115 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 51 drugs (DrugBank) and 92 diseases |
MTOR [1] MTOR 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Sirolimus Sirolimus 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬115. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
116 | Phospholipase D signaling pathway 💬 23 genes, 51 drugs (DrugBank) and 76 diseases |
MTOR [1] MTOR 💬Phospholipase D signaling pathway
|
Sirolimus Sirolimus 💬Phospholipase D signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬116. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
117 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
MTOR [1] MTOR 💬PI3K-Akt signaling pathway
|
Sirolimus Sirolimus 💬PI3K-Akt signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬117. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
118 | Prion disease 💬 41 genes, 66 drugs (DrugBank) and 107 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Prion disease
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
119 | Prostate cancer 💬 22 genes, 51 drugs (DrugBank) and 80 diseases |
MTOR [1] MTOR 💬Prostate cancer
|
Sirolimus Sirolimus 💬Prostate cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬119. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
120 | Proteoglycans in cancer 💬 30 genes, 68 drugs (DrugBank) and 96 diseases |
MTOR [1] MTOR 💬Proteoglycans in cancer
|
Sirolimus Sirolimus 💬Proteoglycans in cancer
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬120. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
121 | Proximal tubule bicarbonate reclamation 💬 6 genes, 6 drugs (DrugBank) and 19 diseases |
CA2 [2] CA2, CA4 💬
|
Topiramate Topiramate 💬Proximal tubule bicarbonate reclamation
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
122 | Rap1 signaling pathway 💬 42 genes, 101 drugs (DrugBank) and 85 diseases |
CNR1 [1] CNR1 💬Rap1 signaling pathway
|
Cannabidiol Cannabidiol 💬Rap1 signaling pathway
| Cannabidiol | 002 [20] 2 , 6 , 8 , 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬122. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
123 | Rap1 signaling pathway 💬 42 genes, 101 drugs (DrugBank) and 85 diseases |
CNR1 [1] CNR1 💬Rap1 signaling pathway
|
Rimonabant Rimonabant 💬Rap1 signaling pathway
| Rimonabant | 193 [1] 193 💬123. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
124 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 69 diseases |
ADRB1 [1] ADRB1 💬Regulation of lipolysis in adipocytes
|
Metoprolol Metoprolol 💬Regulation of lipolysis in adipocytes
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
125 | Renin secretion 💬 28 genes, 82 drugs (DrugBank) and 107 diseases |
ADRB1 [1] ADRB1 💬Renin secretion
|
Metoprolol Metoprolol 💬Renin secretion
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
126 | Renin secretion 💬 28 genes, 82 drugs (DrugBank) and 107 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Renin secretion
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
127 | Retrograde endocannabinoid signaling 💬 34 genes, 62 drugs (DrugBank) and 67 diseases |
CACNA1C [24] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4 💬Retrograde endocannabinoid signaling
|
Topiramate Topiramate 💬Retrograde endocannabinoid signaling
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
128 | Retrograde endocannabinoid signaling 💬 34 genes, 62 drugs (DrugBank) and 67 diseases |
CNR1 [1] CNR1 💬Retrograde endocannabinoid signaling
|
Cannabidiol Cannabidiol 💬Retrograde endocannabinoid signaling
| Cannabidiol | 002 [20] 2 , 6 , 8 , 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬128. Retrograde endocannabinoid signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
129 | Retrograde endocannabinoid signaling 💬 34 genes, 62 drugs (DrugBank) and 67 diseases |
CNR1 [1] CNR1 💬Retrograde endocannabinoid signaling
|
Rimonabant Rimonabant 💬Retrograde endocannabinoid signaling
| Rimonabant | 193 [1] 193 💬129. Retrograde endocannabinoid signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
130 | Salivary secretion 💬 19 genes, 61 drugs (DrugBank) and 56 diseases |
ADRB1 [1] ADRB1 💬Salivary secretion
|
Metoprolol Metoprolol 💬Salivary secretion
| Metoprolol | 017 [6] 17, 57, 58, 113, 193, 226 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
131 | Serotonergic synapse 💬 38 genes, 112 drugs (DrugBank) and 79 diseases |
CACNA1C [7] CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRB1, GABRB2, GABRB3 💬Serotonergic synapse
|
Topiramate Topiramate 💬Serotonergic synapse
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
132 | Shigellosis 💬 23 genes, 41 drugs (DrugBank) and 86 diseases |
MTOR [1] MTOR 💬Shigellosis
|
Sirolimus Sirolimus 💬Shigellosis
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬132. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
133 | Spinocerebellar ataxia 💬 17 genes, 25 drugs (DrugBank) and 70 diseases |
GRIA1 [3] GRIA1, GRIA2, GRIA3 💬
|
Topiramate Topiramate 💬Spinocerebellar ataxia
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
134 | Spinocerebellar ataxia 💬 17 genes, 25 drugs (DrugBank) and 70 diseases |
MTOR [1] MTOR 💬Spinocerebellar ataxia
|
Sirolimus Sirolimus 💬Spinocerebellar ataxia
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬134. Spinocerebellar ataxia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
135 | Steroid hormone biosynthesis 💬 8 genes, 11 drugs (DrugBank) and 14 diseases |
CYP19A1 [1] CYP19A1 💬Steroid hormone biosynthesis
|
Anastrozole Anastrozole 💬Steroid hormone biosynthesis
| Anastrozole | 078 [3] 78, 86, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
136 | Taste transduction 💬 30 genes, 81 drugs (DrugBank) and 65 diseases |
CACNA1C [10] CACNA1C, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, SCN2A, SCN3A, SCN9A 💬Taste transduction
|
Topiramate Topiramate 💬Taste transduction
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
137 | Th17 cell differentiation 💬 43 genes, 66 drugs (DrugBank) and 97 diseases |
MTOR [1] MTOR 💬Th17 cell differentiation
|
Sirolimus Sirolimus 💬Th17 cell differentiation
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬137. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
138 | Thermogenesis 💬 17 genes, 29 drugs (DrugBank) and 82 diseases |
CNR1 [1] CNR1 💬Thermogenesis
|
Cannabidiol Cannabidiol 💬Thermogenesis
| Cannabidiol | 002 [20] 2 , 6 , 8 , 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬138. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
139 | Thermogenesis 💬 17 genes, 29 drugs (DrugBank) and 82 diseases |
CNR1 [1] CNR1 💬Thermogenesis
|
Rimonabant Rimonabant 💬Thermogenesis
| Rimonabant | 193 [1] 193 💬139. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
140 | Thermogenesis 💬 17 genes, 29 drugs (DrugBank) and 82 diseases |
MTOR [1] MTOR 💬Thermogenesis
|
Sirolimus Sirolimus 💬Thermogenesis
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬140. Thermogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
141 | Thyroid hormone signaling pathway 💬 24 genes, 41 drugs (DrugBank) and 67 diseases |
MTOR [1] MTOR 💬Thyroid hormone signaling pathway
|
Sirolimus Sirolimus 💬Thyroid hormone signaling pathway
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬141. Thyroid hormone signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
142 | Tight junction 💬 11 genes, 29 drugs (DrugBank) and 45 diseases |
CACNA1D [1] CACNA1D 💬Tight junction
|
Topiramate Topiramate 💬Tight junction
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
143 | Transcriptional misregulation in cancer 💬 26 genes, 49 drugs (DrugBank) and 76 diseases |
GRIA3 [1] GRIA3 💬Transcriptional misregulation in cancer
|
Topiramate Topiramate 💬Transcriptional misregulation in cancer
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
144 | Type II diabetes mellitus 💬 14 genes, 39 drugs (DrugBank) and 91 diseases |
ABCC8 [2] ABCC8, KCNJ11 💬
|
Diazoxide Diazoxide 💬Type II diabetes mellitus
| Diazoxide | 013 [2] 13, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
145 | Type II diabetes mellitus 💬 14 genes, 39 drugs (DrugBank) and 91 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Topiramate Topiramate 💬Type II diabetes mellitus
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
146 | Type II diabetes mellitus 💬 14 genes, 39 drugs (DrugBank) and 91 diseases |
MTOR [1] MTOR 💬Type II diabetes mellitus
|
Sirolimus Sirolimus 💬Type II diabetes mellitus
| Sirolimus | 002 [40] 2 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 💬146. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
147 | Vascular smooth muscle contraction 💬 31 genes, 77 drugs (DrugBank) and 68 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Topiramate Topiramate 💬Vascular smooth muscle contraction
| Topiramate | 006 [6] 6 , 97, 140, 144, 156, 193 💬
|
ABC transporters
3 genes, 10 drugs (DrugBank) and 8 diseases
Acute myeloid leukemia
17 genes, 30 drugs (DrugBank) and 62 diseases
Adipocytokine signaling pathway
16 genes, 31 drugs (DrugBank) and 95 diseases
Adrenergic signaling in cardiomyocytes
27 genes, 80 drugs (DrugBank) and 71 diseases
Aldosterone synthesis and secretion
20 genes, 38 drugs (DrugBank) and 62 diseases
Alzheimer disease
55 genes, 116 drugs (DrugBank) and 122 diseases
Amphetamine addiction
25 genes, 51 drugs (DrugBank) and 91 diseases
AMPK signaling pathway
16 genes, 49 drugs (DrugBank) and 93 diseases
Amyotrophic lateral sclerosis
35 genes, 48 drugs (DrugBank) and 108 diseases
Apelin signaling pathway
12 genes, 30 drugs (DrugBank) and 72 diseases
Arrhythmogenic right ventricular cardiomyopathy
11 genes, 24 drugs (DrugBank) and 28 diseases
Autophagy - animal
13 genes, 18 drugs (DrugBank) and 62 diseases
Autophagy - other
1 gene, 3 drugs (DrugBank) and 41 diseases
Bile secretion
11 genes, 29 drugs (DrugBank) and 60 diseases
Breast cancer
21 genes, 60 drugs (DrugBank) and 74 diseases
Calcium signaling pathway
79 genes, 187 drugs (DrugBank) and 134 diseases
cAMP signaling pathway
67 genes, 171 drugs (DrugBank) and 114 diseases
Carbohydrate digestion and absorption
14 genes, 19 drugs (DrugBank) and 30 diseases
Cardiac muscle contraction
13 genes, 17 drugs (DrugBank) and 26 diseases
Cellular senescence
26 genes, 40 drugs (DrugBank) and 92 diseases
Central carbon metabolism in cancer
18 genes, 29 drugs (DrugBank) and 56 diseases
cGMP-PKG signaling pathway
46 genes, 119 drugs (DrugBank) and 118 diseases
Chemical carcinogenesis - receptor activation
39 genes, 126 drugs (DrugBank) and 116 diseases
Choline metabolism in cancer
11 genes, 25 drugs (DrugBank) and 53 diseases
Cholinergic synapse
32 genes, 48 drugs (DrugBank) and 59 diseases
Circadian entrainment
22 genes, 32 drugs (DrugBank) and 55 diseases
Cocaine addiction
15 genes, 63 drugs (DrugBank) and 52 diseases
Collecting duct acid secretion
3 genes, 11 drugs (DrugBank) and 35 diseases
Colorectal cancer
14 genes, 23 drugs (DrugBank) and 49 diseases
Cortisol synthesis and secretion
15 genes, 33 drugs (DrugBank) and 61 diseases
Cushing syndrome
24 genes, 50 drugs (DrugBank) and 66 diseases
Diabetic cardiomyopathy
26 genes, 42 drugs (DrugBank) and 73 diseases
Dilated cardiomyopathy
17 genes, 55 drugs (DrugBank) and 83 diseases
Dopaminergic synapse
31 genes, 99 drugs (DrugBank) and 101 diseases
EGFR tyrosine kinase inhibitor resistance
26 genes, 56 drugs (DrugBank) and 83 diseases
Endocrine resistance
20 genes, 43 drugs (DrugBank) and 62 diseases
ErbB signaling pathway
14 genes, 26 drugs (DrugBank) and 53 diseases
GABAergic synapse
29 genes, 38 drugs (DrugBank) and 55 diseases
Gap junction
26 genes, 87 drugs (DrugBank) and 77 diseases
Gastric acid secretion
14 genes, 43 drugs (DrugBank) and 52 diseases
Gastric cancer
21 genes, 34 drugs (DrugBank) and 57 diseases
Glioma
15 genes, 30 drugs (DrugBank) and 57 diseases
Glutamatergic synapse
23 genes, 27 drugs (DrugBank) and 83 diseases
GnRH secretion
20 genes, 42 drugs (DrugBank) and 54 diseases
GnRH signaling pathway
16 genes, 36 drugs (DrugBank) and 37 diseases
Growth hormone synthesis, secretion and action
24 genes, 41 drugs (DrugBank) and 76 diseases
Hepatocellular carcinoma
21 genes, 31 drugs (DrugBank) and 57 diseases
Herpes simplex virus 1 infection
43 genes, 65 drugs (DrugBank) and 94 diseases
HIF-1 signaling pathway
23 genes, 48 drugs (DrugBank) and 76 diseases
Human cytomegalovirus infection
56 genes, 104 drugs (DrugBank) and 120 diseases
Human immunodeficiency virus 1 infection
41 genes, 43 drugs (DrugBank) and 89 diseases
Human papillomavirus infection
40 genes, 91 drugs (DrugBank) and 105 diseases
Huntington disease
24 genes, 33 drugs (DrugBank) and 82 diseases
Hypertrophic cardiomyopathy
20 genes, 51 drugs (DrugBank) and 87 diseases
Insulin resistance
18 genes, 33 drugs (DrugBank) and 95 diseases
Insulin secretion
14 genes, 39 drugs (DrugBank) and 44 diseases
Insulin signaling pathway
12 genes, 26 drugs (DrugBank) and 66 diseases
JAK-STAT signaling pathway
58 genes, 91 drugs (DrugBank) and 96 diseases
Kaposi sarcoma-associated herpesvirus infection
50 genes, 84 drugs (DrugBank) and 108 diseases
Long-term depression
13 genes, 19 drugs (DrugBank) and 32 diseases
Long-term potentiation
18 genes, 33 drugs (DrugBank) and 86 diseases
Longevity regulating pathway
11 genes, 20 drugs (DrugBank) and 68 diseases
Longevity regulating pathway - multiple species
11 genes, 15 drugs (DrugBank) and 62 diseases
MAPK signaling pathway
61 genes, 85 drugs (DrugBank) and 110 diseases
Metabolic pathways
111 genes, 155 drugs (DrugBank) and 137 diseases
MicroRNAs in cancer
31 genes, 65 drugs (DrugBank) and 85 diseases
Morphine addiction
41 genes, 65 drugs (DrugBank) and 73 diseases
mTOR signaling pathway
14 genes, 32 drugs (DrugBank) and 91 diseases
Neuroactive ligand-receptor interaction
149 genes, 320 drugs (DrugBank) and 153 diseases
Neutrophil extracellular trap formation
35 genes, 36 drugs (DrugBank) and 61 diseases
Nicotine addiction
30 genes, 30 drugs (DrugBank) and 44 diseases
Nitrogen metabolism
14 genes, 5 drugs (DrugBank) and 18 diseases
Ovarian steroidogenesis
7 genes, 36 drugs (DrugBank) and 52 diseases
Oxytocin signaling pathway
34 genes, 73 drugs (DrugBank) and 108 diseases
Pancreatic cancer
19 genes, 36 drugs (DrugBank) and 67 diseases
Pancreatic secretion
13 genes, 35 drugs (DrugBank) and 36 diseases
Pathways in cancer
104 genes, 194 drugs (DrugBank) and 133 diseases
Pathways of neurodegeneration - multiple diseases
59 genes, 120 drugs (DrugBank) and 125 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
34 genes, 51 drugs (DrugBank) and 92 diseases
Phospholipase D signaling pathway
23 genes, 51 drugs (DrugBank) and 76 diseases
PI3K-Akt signaling pathway
76 genes, 112 drugs (DrugBank) and 112 diseases
Prion disease
41 genes, 66 drugs (DrugBank) and 107 diseases
Prostate cancer
22 genes, 51 drugs (DrugBank) and 80 diseases
Proteoglycans in cancer
30 genes, 68 drugs (DrugBank) and 96 diseases
Proximal tubule bicarbonate reclamation
6 genes, 6 drugs (DrugBank) and 19 diseases
Rap1 signaling pathway
42 genes, 101 drugs (DrugBank) and 85 diseases
Regulation of lipolysis in adipocytes
13 genes, 71 drugs (DrugBank) and 69 diseases
Renin secretion
28 genes, 82 drugs (DrugBank) and 107 diseases
Retrograde endocannabinoid signaling
34 genes, 62 drugs (DrugBank) and 67 diseases
Salivary secretion
19 genes, 61 drugs (DrugBank) and 56 diseases
Serotonergic synapse
38 genes, 112 drugs (DrugBank) and 79 diseases
Shigellosis
23 genes, 41 drugs (DrugBank) and 86 diseases
Spinocerebellar ataxia
17 genes, 25 drugs (DrugBank) and 70 diseases
Steroid hormone biosynthesis
8 genes, 11 drugs (DrugBank) and 14 diseases
Taste transduction
30 genes, 81 drugs (DrugBank) and 65 diseases
Th17 cell differentiation
43 genes, 66 drugs (DrugBank) and 97 diseases
Thermogenesis
17 genes, 29 drugs (DrugBank) and 82 diseases
Thyroid hormone signaling pathway
24 genes, 41 drugs (DrugBank) and 67 diseases
Tight junction
11 genes, 29 drugs (DrugBank) and 45 diseases
Transcriptional misregulation in cancer
26 genes, 49 drugs (DrugBank) and 76 diseases
Type II diabetes mellitus
14 genes, 39 drugs (DrugBank) and 91 diseases
Vascular smooth muscle contraction
31 genes, 77 drugs (DrugBank) and 68 diseases